The first report from a phase II, multi-center clinical trial indicates that a newer, more aggressive form of radiation therapy—stereotactic radiation—can extend long-term survival for some patients with stage-IV cancers ...
Jan 31, 2019
0
0
A drug increasingly used in combination with radiotherapy to treat a type of cancer that forms in the tonsils or the base of the tongue is inferior to a previously favored option, according to a large, clinical trial led ...
Nov 16, 2018
0
8
(HealthDay)—In addition to fear of pain and suffering, Americans worry about cancer-related expenses, according to the results of the American Society of Clinical Oncology (ASCO) 2018 National Cancer Opinion Survey.
Nov 6, 2018
0
0
While most oncologists would agree that exercise is important for people with cancer, generic guidelines for this population do not address the high need for personalized exercises.
Oct 5, 2018
0
3
A substantial proportion of pharmaceutical industry payments to authors of oncology clinical trials published in major scientific journals are not disclosed, new research shows. The publications focused on clinical trials ...
Aug 30, 2018
0
3
(HealthDay)—The American Society for Clinical Oncology (ASCO) has endorsed the Society for Integrative Oncology (SIO) guideline on the use of integrative therapies during and after breast cancer treatment, according to ...
Aug 4, 2018
0
0
(HealthDay)—Females with head and neck cancer (HNC) are less likely to receive intensive chemotherapy and radiation, and have an increased relative risk for death from HNC versus other causes, according to a study presented ...
Jun 7, 2018
0
4
By taking a high-cost drug with a low-fat meal—instead of on an empty stomach, as prescribed—prostate cancer patients could decrease their daily dose, prevent digestive issues and cut costs by 75 percent, according to ...
Mar 28, 2018
0
49
Results of an analysis from the University of Cincinnati (UC) College of Medicine show that additional therapy, or adjuvant therapy, delivered after surgical removal of a rare type of gastrointestinal tumor does not increase ...
Mar 25, 2018
0
8
(HealthDay)—There is little evidence for the clinical validity or utility of circulating tumor DNA (ctDNA) assays for solid tumors, according to a special article published online March 5 in the Journal of Clinical Oncology.
Mar 5, 2018
0
3
